0.5 |
1.5 |
GO:0007621 |
negative regulation of female receptivity(GO:0007621) |
0.2 |
0.5 |
GO:0071873 |
response to norepinephrine(GO:0071873) |
0.2 |
0.5 |
GO:0003195 |
tricuspid valve development(GO:0003175) tricuspid valve morphogenesis(GO:0003186) tricuspid valve formation(GO:0003195) right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.1 |
2.3 |
GO:0050901 |
leukocyte tethering or rolling(GO:0050901) |
0.1 |
0.7 |
GO:1902897 |
regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.1 |
1.0 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
0.1 |
0.3 |
GO:0010751 |
regulation of arginine metabolic process(GO:0000821) negative regulation of nitric oxide mediated signal transduction(GO:0010751) negative regulation of cellular amino acid metabolic process(GO:0045763) |
0.1 |
4.0 |
GO:0030901 |
midbrain development(GO:0030901) |
0.1 |
0.6 |
GO:0060501 |
positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
0.1 |
1.3 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
0.1 |
1.3 |
GO:0007617 |
mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.1 |
0.3 |
GO:0071955 |
recycling endosome to Golgi transport(GO:0071955) |
0.1 |
0.2 |
GO:2000744 |
anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
0.0 |
0.1 |
GO:0097623 |
potassium ion export across plasma membrane(GO:0097623) |
0.0 |
0.2 |
GO:0010908 |
regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.0 |
0.1 |
GO:2001187 |
positive regulation of CD8-positive, alpha-beta T cell activation(GO:2001187) |
0.0 |
0.5 |
GO:2000251 |
positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.0 |
0.3 |
GO:0051103 |
DNA ligation involved in DNA repair(GO:0051103) |
0.0 |
0.2 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
0.0 |
0.3 |
GO:1901621 |
negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.0 |
0.2 |
GO:0070474 |
positive regulation of uterine smooth muscle contraction(GO:0070474) |
0.0 |
0.9 |
GO:0071480 |
cellular response to gamma radiation(GO:0071480) |
0.0 |
0.1 |
GO:0051902 |
negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.0 |
0.2 |
GO:0008300 |
isoprenoid catabolic process(GO:0008300) |
0.0 |
0.4 |
GO:2001014 |
regulation of skeletal muscle cell differentiation(GO:2001014) |
0.0 |
0.1 |
GO:0002591 |
antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway(GO:0002488) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent(GO:0002489) positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
0.0 |
0.3 |
GO:0032793 |
positive regulation of CREB transcription factor activity(GO:0032793) membrane hyperpolarization(GO:0060081) |
0.0 |
0.2 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.0 |
0.2 |
GO:0007379 |
segment specification(GO:0007379) |
0.0 |
0.1 |
GO:0060023 |
soft palate development(GO:0060023) |
0.0 |
0.1 |
GO:0032911 |
nerve growth factor production(GO:0032902) negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.0 |
0.6 |
GO:0006890 |
retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 |
0.6 |
GO:0007157 |
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.0 |
0.2 |
GO:0010758 |
regulation of macrophage chemotaxis(GO:0010758) |
0.0 |
0.0 |
GO:0000379 |
tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.0 |
0.1 |
GO:0070995 |
NADPH oxidation(GO:0070995) |
0.0 |
0.1 |
GO:0090244 |
Wnt signaling pathway involved in somitogenesis(GO:0090244) |